UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:August 10,
BiondVax Pharmaceuticals (NASDAQ:BVXV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more BiondVax Pharmaceuticals Charts.
BiondVax Pharmaceuticals (NASDAQ:BVXV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more BiondVax Pharmaceuticals Charts.

Biondvax Pharmaceuticals Ltd. News

Form NT 20-F - Notification of inability to timely file Form 20-F
Tuesday 30 April 2024 (6 days ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 16 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG
Wednesday 10 April 2024 (4 weeks ago) • PR Newswire (US)
Form SC 13D - General statement of acquisition of beneficial ownership
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Scinai leadership to attend BIO-Europe Spring 2024
Tuesday 12 March 2024 (2 months ago) • PR Newswire (US)
Scinai Welcomes Liat Halpert as Head of Business Development and Sales
Tuesday 13 February 2024 (3 months ago) • PR Newswire (US)
Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds
Thursday 4 January 2024 (4 months ago) • PR Newswire (US)
Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule
Monday 20 November 2023 (6 months ago) • PR Newswire (US)
Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 7 September 2023 (8 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 6 September 2023 (8 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 6 September 2023 (8 months ago) • Edgar (US Regulatory)
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
Wednesday 6 September 2023 (8 months ago) • GlobeNewswire Inc.

More Biondvax Pharmaceuticals Ltd. News Articles